Increasing Toxicity in Nonoperative Head and Neck Cancer Treatment: Investigations and Interventions

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2 SUPPL., 2007, Pages

  Bentzen, Søren M ^a   Rosenthal, David I ^b   Weymuller, Ernest A ^c   Trotti, Andy ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CETUXIMAB; PALIFERMIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; DOSIMETRY; DYSPHAGIA; EVOLUTION; FOLLOW UP; HEAD AND NECK CANCER; HEALTH PROGRAM; HUMAN; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIOBIOLOGY; SAFETY; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION INJURIES; RADIOBIOLOGY; RISK MANAGEMENT; SURGERY; TERMINOLOGY AS TOPIC;

EID: 34548413296     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.080     Document Type: Article

References (21)

1. Seiwert T.Y., Salama J.K., and Vokes E.E. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 4 (2007) 156-171
2. Temam S., Pape E., Janot F., et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 1078-1083
3. Kendal W. Suicide and cancer: A gender-comparative study. Ann Oncol 18 (2007) 381-387
4. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
5. Lee W.T., Akst L.M., Adelstein D.J., et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 28 (2006) 808-812
6. Gwede C.K., Johnson D.J., Daniels S.S., et al. Assessment of toxicity in cooperative oncology clinical trials: The long and short of it. J Oncol Manag 11 (2002) 15-21
7. Trotti A., Colevas D., Setser A., et al. Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 1 (2003) 176-181
8. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6 (2006) 702-713
9. Trotti A., and Bentzen S.M. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22 (2004) 19-22
10. Bentzen S.M., Dorr W., Anscher M.S., et al. Normal tissue effects: Reporting and analysis. Semin Radiat Oncol 13 (2003) 189-202
11. Bentzen S.M. High-tech in radiation oncology: Should there be a ceiling?. Int J Radiat Oncol Biol Phys 58 (2004) 320-330
12. Rosenthal D.I., and Ang K.K. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. Semin Radiat Oncol 14 (2004) 153-166
13. Mittal B.B., Pauloski B.R., Haraf D.J., et al. Swallowing dysfunction-Preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys 57 (2003) 1219-1230
14. Rosenthal D.I., Lewin J.S., and Eisbruch A. Dysphagia and aspiration: The problem, its prevention and rehabilitation after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
15. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
16. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: Matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1309-1317
17. Garden A. Mucositis: Current management and investigations. Semin Radiat Oncol 13 (2003) 267-273
18. Dorr W., Bassler S., Reichel S., et al. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): Experimental studies in mice. Int J Radiat Oncol Biol Phys 62 (2005) 881-887
19. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
20. Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: The development and validation of the M.D. Anderson symptom inventory, head & neck module (MDASI-HN). Head Neck. Epub 2007.
21. Bentzen S.M., Harari P.M., and Bernier J. Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions. Nat Clin Pract Oncol 4 (2007) 172-180